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The only recognized virulence factor of enterotoxigenic Bacteroides fragilis (ETBF) that
accompanies bloodstream infections is the zinc-dependent non-lethal metalloprotease
B. fragilis toxin (BFT). The isolated toxin stimulates intestinal secretion, resulting in
epithelial damage and necrosis. Numerous publications have focused on the interrelation
of BFT with intestinal inflammation and colorectal neoplasia, but nothing is known about
the mechanism of its secretion and delivery to host cells. However, recent studies of
gram-negative bacteria have shown that outer membrane vesicles (OMVs) could be
an essential mechanism for the spread of a large number of virulence factors. Here,
we show for the first time that BFT is not a freely secreted protease but is associated
with OMVs. Our findings indicate that only outer surface-exposed BFT causes epithelial
cell contact disruption. According to our in silico models confirmed by Trp quenching
assay and NMR, BFT has special interactions with outer membrane components such as
phospholipids and is secreted during vesicle formation. Moreover, the strong cooperation
of BFT with polysaccharides is similar to the behavior of lectins. Understanding the
molecular mechanisms of BFT secretion provides new perspectives for investigating
intestinal inflammation pathogenesis and its prevention.
Keywords: toxin delivery, lipid protein interactions, shot gun lipidomics, Electron microscopy, fluorescence
quenching, NMR
INTRODUCTION
Of the numerousmicrobial species that inhabit the gastrointestinal tract of mammals, Bacteroidetes
is the most abundant gram-negative bacterial phylum (Ley et al., 2008). The anaerobe Bacteroides
fragilis is a common colonic symbiont with an affinity for mucosal colonization, although it makes
up only 1 to 2% of the cultured fecal flora (Huang et al., 2011). There are two molecular subtypes,
non-toxigenic B. fragilis (NTBF) and enterotoxigenic B. fragilis (ETBF). ETBF is an intestinal
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bacterium that has been associated with inflammatory bowel
disease and colorectal cancer in humans (Prindiville et al., 2000;
Toprak et al., 2006). The only well-studied virulence factor
specific to ETBF is the secreted metalloprotease B. fragilis toxin
(BFT) (Moncrief et al., 1995; Franco et al., 1997). BFT can
affect zonula adherens and tight junctions in the intestinal
epithelium by cleaving E-cadherin (Wu et al., 1998), resulting in
rearrangements of the actin cytoskeleton of epithelial cells. BFT
is synthesized as a 44.4-kDa precursor (pBFT), which is then
processed into a 21-kDa mature BFT (mBFT) that is secreted
into the supernatant of cultured cells (Kling et al., 1997). Three
toxin isoforms have been described, BFT1, BFT2, and BFT3,
with isoform BFT2 being the most common (Scotto d’Abusco
et al., 2000). Although BFT is a secreted protease, nothing is
known about the mechanisms of its secretion and transport
to host cells. Gram-negative bacteria have evolved mechanisms
to deliver virulence factors to the host (Koster et al., 2000).
Well-studied examples include type III secretion systems (Galán
et al., 2014), type IV secretion systems (Wallden et al., 2010),
and type VI secretion systems, which are required for virulence
factor transport to host cells (Hachani et al., 2016). Genomic
studies of B. fragilis have not shown evidence of type III, IV,
autotransporter, or two-partner secretion systems (Wilson et al.,
2015). However, B. fragilis was shown to possess genes for Hly
type I secretion systems, which are similar to the hemolysin type
I secretion system HlyDb of Escherichia coli (Wang et al., 1991).
Type VI secretion systems (T6SS) were recently discovered in
a few Bacteroidetes strains, thereby extending the presence of
these systems beyond Proteobacteria. Comprehensive analysis of
all sequenced human gut Bacteroidales strains has shown that
more than half contain T6SS loci (Coyne et al., 2016). T6SS as
a multiprotein complex is specially organized into three distinct
genetic architectures (GA) where GA1 and GA2 loci are present
on conserved integrative conjugative elements (ICE) and are
transferred and shared among diverse human gut Bacteroidales
species. But GA3 loci are not contained on conserved ICE and
are confined to B. fragilis. Thorough research has showed that
GA3 loci of B. fragilis could be a source of numerous novel
effector and immunity proteins (Chatzidaki-Livanis et al., 2016).
But there is no evidence that T6SSmay be used for B. fragilis toxin
secretion.
Rather than secrete virulence factors into the surrounding
milieu, where they could be degraded by host proteases,
many gram-negative pathogens utilize outer membrane vesicles
(OMVs) as a mechanism of delivering active proteins and
other moieties into host cells (Kulp and Kuehn, 2010). Toxin
delivery mediated by OMVs is recognized as a potent virulence
mechanism for many pathogens (Ellis and Kuehn, 2010). It is
now well known that both non-pathogenic and pathogenic gram-
negative bacteria constitutively release OMVs (Kuehn and Kesty,
2005). OMVs are spherical proteoliposomes that have an average
diameter ranging from 20 to 150 nm and that are enriched with
outer membrane proteins, phospholipids, polysaccharides, and
numerous proteins of a wide molecular mass range (Mashburn-
Warren et al., 2008). Many periplasm-located virulence factors
are enriched in OMVs, including Shiga toxin produced by E.
coli and Cag toxin produced by Helicobacter pylori (Ismail et al.,
2003; Kesty and Kuehn, 2004). The large number of enzyme-
containing OMVs produced by B. fragilis suggests that OMV
transport may be an important export pathway (Patrick et al.,
1996; Cerdeño-Tárraga et al., 2005). Intracellular, periplasmic
and outer membrane-bound proteases have been identified in
B. fragilis (Elhenawy et al., 2014). Moreover, B. fragilis OMVs
which contain surface located polysaccharide A have been shown
to play an anti-inflammatory role by acting on regulatory T
(Treg) cells (Shen et al., 2012). Many hydrolytic enzymes, which
are generally considered pathogenic factors, may be bound to
the membrane and/or secreted (Gibson and Macfarlane, 1988).
Toxins secreted by enterotoxigenic E. coli and V. cholerae have
been found to associate with LPS on the outer surface of
OMVs (Horstman and Kuehn, 2002; Chatterjee and Chaudhuri,
2011), in a manner similar to lectins. Lectins are usually
characterized by weak interactions between carbohydrates and
proteins through hydrogen and coordinate bonds (Richards
et al., 1979). Because the B. fragilis genome does not encode for
known secretion system genes involved in BFT secretion and
transport, we reasoned that BFT might be delivered to host cells
by OMVs. Consequently, the toxin is incorporated in vesicle
membranes during membrane formation due to interactions
with outer membrane components, such as lipids and LPS. In the
present study, we demonstrate that BFT is associated with OMV
membranes through hydrophobic and electrostatic interactions
and forms hydrogen and coordinate bonds with membrane
components, similar to the behavior of lectins.
RESULTS
OMV Production by NTBF and ETBF and
BFT2 Detection in Association with OMVs
To analyze the surface structure of both NTBF and ETBF strains,
we examined the bacteria by TEM, which revealed the formation
of OMVs on the cell surface (Figure 1A). It was observed that
both strains (ETBF and NTBF) of B. fragilis produce vesicles
(Figures 1A,B for ETBF and Supplementary Figures 2A,B for
NTBF) with sizes ranging from 20 to 100 nm (Figure 1C).
To avoid contamination with bacteria, small volume of OMV
containing solution were cultivated on blood agar plates under
anaerobic conditions for 2 days. B. fragilis colonies were not
observed on blood agar plates.
After isolation of OMV containing fraction from 250ml
cultured cells, we measured the total protein concentration
of the ETBF and NTBF OMV preparations, which was ∼40–
60µg in 50µl. For toxin detection, we analyzed 40µg ETBF
and NTBF OMV preparations by western blot using polyclonal
antibodies (anti-BFT2) specific to mBFT2 and pBFT2. As a
result, we observed the association of mBFT2 with ETBF vesicles
(Figure 1D). OMV-depleted medium was also used for toxin
detection. Briefly, 100 ml OMV-free medium was lyophilized
under reduced pressure by a rotary evaporator and analyzed
by western blot with polyclonal antibodies (anti-BFT2). We did
not detect any visible amount of free toxin. pBFT2 was not
detected in the OMV fraction or in OMV-depleted medium.
The cells fractions were also examined for toxin existence by
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FIGURE 1 | B. fragilis produces outer membrane vesicles (OMV), containing BFT. TEM of thin section of ETBF cells during vesicle production (A) and isolated
ETBF OMVs (B), at magnification: x 10,000. Scale bars represent 1µm for (A) and 300 nm for (B). (C) OMV size distribution diagram determined from measurements
of about 1000 OMVs from 10 samples (D)–5µg of extracted OMV proteins of each strain (ETBF–1; NTBF–2) were run on 10% SDS-PAGE followed by western blot
with antibody against BFT2. 100 ng of each recombinant forms of the toxin were also added (3–mBFT2 and 4–pBFT2).
western blot using polyclonal antibodies (anti-BFT2) specific to
mBFT2 and pBFT2. As a result we detected major part of the
pBFT2 in membrane fraction and small amount of pBFT2 in
periplasm fraction of ETBF cells (Supplementary Figures 1A,B).
We examined cells fractions by Q-TOF analysis (Supplementary
Information 1).
To confirm the localization of the toxin in the bacterial
membrane and in the OMV preparation, we performed
immunoelectron microscopic analyses of thin sections using
gold nanoparticles coupled with anti-BFT2 antibodies. We
detected gold particles coupled with anti-BFT2 antibodies on
the membrane and in the periplasm of ETBF (Figures 2A,C,
indicated by arrow), which confirmed the previous results
obtained by western blot analysis. There was no labeling of the
same structure in NTBF cells (Figure 2H and Supplementary
Figure 2A). We observed several labels located in the cytoplasm
of bacterial cells, potentially indicating toxin formation
(Figures 2B–D). Dynamics of OMV formation and release from
the bacterial cell surface were monitored (Figure 2B, indicated
by arrow). Importantly, we observed label predominantly located
on the outer membrane (Figure 2D, indicated by arrow). ETBF
and NTBF OMV samples were negatively stained and labeled
with anti-BFT2 antibodies coupled with gold particles. We also
examined freely isolated OMVs preparation for toxin localization
by immunogold staining. We observed that the label was located
on the surface of the ETBF OMV, indicating that the toxin was
associated with the outer membrane (Figures 2E–G). There was
no labeling of the same structure in NTBF OMVs (Figure 2I and
Supplementary Figure 2B).
Shot-Gun Lipidomics of the B. fragilis
Outer Membrane
To detect the components of the B. fragilis membrane,
which the toxin could potentially interact with, shot-gun mass
spectrometric analysis of the isolated membrane lipids and
LPS extracts was performed. In the fragmentation spectra of
membrane lipids, we primarily detected characteristic ions of
polar groups of phospholipids, variable fatty acid residues capable
of forming different diacylglycerol esters, cycles, and other
compounds with water loss. The full list of the identified ions is
shown in Supplementary information 2 (Table 1). As expected,
the most represented ions in the spectrum belonged to the classes
of phosphatidylethanolamine (PE), phosphatidylcholine (PC),
and diacylglycerol (DG) (Figure 3).
To determine the specific molecular structure of B. fragilis
LPS, we performed comprehensive mass spectrometry analysis.
We used the Tri-Reagent method to extract LPS from B.
fragilis cell membranes (Elhenawy et al., 2014). To profile
the extracted LPS, we used direct injection electrospray-
time-of-flight mass spectrometry in negative ion mode as
described in the Materials and Methods section. As a result,
we identified 38 different LPS compounds in the B. fragilis LPS
preparation [Supplementary information 2 (Table 2)]. Among
the detected ions, we reliably identified lipid A-disaccharide-1-P,
3-deoxy-D-manno-octulosonyl-lipid IV(A), KDNalpha2-
3Galbeta1-4Glcbeta-Cer[d18:1/24:1(15Z)] and numerous
galactosylceramides and glucosylceramides (polysaccharide
chains consisting of 4 to 8 carbohydrate units). The identified
lipid A-disaccharide-1-P structure was the same as that
previously described by Elhenawy et al. (Patrick et al., 1996). As
expected, the most represented ions in the spectrum belonged
to classes of cerebrosides that are normally produced by B.
fragilis cells. The mass spectrometry metabolomic data have
been deposited to UCSD Center for Computational Mass
Spectrometry (MassIVE ID: MSV000080382).
Modeling and Docking of Phospholipids
(PC and PE), lipid A, Polysaccharide Chain,
and BFT2 (mBFT2, pBFT2)
Two phospholipids of the most abundant classes represented
in B. fragilis membranes (PC and PE) according to our
shot-gun lipidomics data and the main components of
LPS [lipid A and polysaccharide chain (PSC)] were docked
to pBFT2 and mBFT2 surfaces. Modeling of the pBFT2
and mBFT2 surfaces according to hydrophobic potential
distribution, cavities, and potential donors and acceptors
of hydrogen bond distribution is shown in Supplementary
Figures 3, 4.
The conformations of mBFT2 complexes with PE, PC, lipid
A, and PSC with best values of binding energies are shown
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FIGURE 2 | Identification of toxin cell and OMV localization via immune-microscopy with antibodies against BFT. (A–D) Thin sections of ETBF cells
analyzed by TEM contain some labels (black dots) coupled with antibodies against BFT fixed on periplasm and membrane (indicated by arrow). Several labels coupled
with antibodies against BFT fixed on cytoplasm indicating probable toxin formation. Scale bars represent 300 nm for (A) and (D), 500 nm for (B) and (C).
(E–G)—Negatively stained OMV preparations isolated from ETBF culture and coincubated with labels, (black dots indicated by arrow) coupled with antibodies against
BFT were analyzed by TEM. Scale bars represent 100 nm for (E,F) and 150 nm for (G). (H) Thin section of NTBF cells analyzed by TEM contains no fixed labels
coupled with antibodies against BFT. (I) Negatively stained OMV preparations isolated from NTBF culture contain no fixed labels coupled with antibodies against BFT.
Scale bars represent 600 nm for (H) and 400 nm for (I).
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FIGURE 3 | Full mass spectra of B. fragilis lipids show the most represented lipids of B. fragilis membrane. (A) MS analysis of ETBF (colored in red) and
NTBF (colored in blue) membrane in positive linear mode. (B) MS analysis of ETBF (colored in red) and NTBF (colored in blue) membrane in negative linear mode. B.
fragilis cells membrane lipids were extracted by Folch method (see material and methods), dissolved in 200 µl ethanol and analyzed by quadruple time-of-flight
tandem mass spectrometer. Mass spectrum of ETBF and NTBF in positive and negative linear mode showed the same cluster of peaks, indicating the most
represented classes of lipids (PC, PE, DG, PA).
in Figures 4, 5. As is evident from Supplementary information
2 (Table 3), hydrophobic interactions as well as electrostatic
make a significant contribution (∆Gnon−polar) to the binding
energy upon complex formation for both proteins (mBFT2
and pBFT2). The Coulomb contribution (∆Gel) in the case of
pBFT2 complex formation is insignificant (∆Gel comparable to
∆Gnon−polar) compared with mBFT2 complex formation due to
the latter’s interaction with the zinc ion. Furthermore, the loss
of conformational mobility during binding by the ligand as well
as by the target leads to a decrease in entropy (T1S) which
reduces binding energy. Also note that electrostatic component
of solvation energy (∆Gpolar) significantly decreases binding
energy.
Lipids can form H-bonds with amino acid residues on
pBFT2/mBFT2 groove surfaces (Supplementary Figures 5, 6,
PC acts as an acceptor, and PE can be either a donor or an
acceptor).
Importantly, the nitrogen group of PE tends to form donor-
acceptor bonds with amino acids located in the mBFT2 cavity
(Figure 4A, indicated by arrow). In contrast, hydrophobic
contributions are greater in the case of pBFT2 probably due to
the larger size of the pBFT2 surface groove compared to that of
mBFT2.
Lipid A, as a main component of LPS, also forms H-
bonds with amino acid residues on the mBFT2 groove surface
(Figure 5A). The lipid A molecule contains two-fold the amount
of fatty acid residues compared to PE and PC and therefore
makes a significant hydrophobic contribution to mBFT2-lipid
A complex formation [(Supplementary information 2 (Table
3)]. In accordance with Elhenawy et al., the lipid A molecule
contains a phosphate group, but PSC may exist without the
phosphate group in an aqueous medium (Elhenawy et al., 2014).
PSC is composed of long chains of monosaccharide units bound
together by glycosidic linkages, which form multiple H-bonds
with mBFT2 amino acids (Figure 5C). These interactions may
have a significant impact on polysaccharide chain-mBFT2
complex formation.
Importantly, non-ester phosphate oxygen atoms of PC/PE
(Figures 4B,D), lipid A (Figure 5B), and PSC (Figure 5D) tend
to form coordinate bonds with the zinc ion in the active center
of mBFT2. Carbonyl oxygen atoms of PC/PE might also form
such bonds with the zinc ion. According to our data, electrostatic
contributions are higher for the lipid-mBFT2 complex than for
the lipid-pBFT2 complex, indicating possible coordinate bond
formation [∆Gel (PE+pBFT); ∆Gel (PC+pBFT) < ∆Gel (PE+mBFT);
∆Gel (PC+mBFT)] [(Supplementary information 2 (Table 3)].
Trp Fluorescence Quenching Assay and
1H-NMR Spectroscopy of BFT-Lipid
Complexes
In the above molecular modeling and docking experiments,
we identified the most abundant classes of phospholipids of
the B. fragilis membrane (PE and PC) and demonstrated their
interaction with the mBFT2 and pBFT2 surfaces in silico. Next,
the propensity of mBFT2 and pBFT2 to form complexes with
PC was tested using 1H-NMR and Trp fluorescence quenching
(Figure 6). Comparison of NMR spectra of PC alone and PC
mixed with pBFT2/mBFT2 (Figures 6A,B) revealed changes in
the chemical shifts and peak widths of the fatty acid signals (0—4
ppm), which indicated changes in PC conformation and mobility
upon complex formation.
The Trp fluorescence quenching assay, a popular method for
investigating lipid-protein interactions (Dua et al., 1995; Kraft
et al., 2009), was chosen because BFT2 contains 4 Trp residues in
its catalytic site. Proteinase K was used as a negative control, and
BSA, which is known to bind lipids in the medium nanomolar
range (Charbonneau and Tajmir-Riahi, 2010), was used as a
positive control. Intrinsic protein fluorescence was monitored
at the Trp/Tyr emission maximum upon excitation at 295 nm
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FIGURE 4 | Structure model of mBFT and best (according to the binding energy) ligands (A)—PC and (C)—PE location on the mBFT Conolly surface,
painted depending on the values of the hydrophobic potential—green, donors—blue, acceptors—red, resulting docking via ICM. The atoms of the ligands are painted
in the following colors: polar hydrogens—blue, nitrogen—dark blue, oxygen—red, phosphorus—orange, carbon—white. Zn ions are painted in blue. The non-polar
hydrogens not shown. Black dot lines indicate hydrogen bonds. Oxygen of lipid phosphate group colored in red forming coordination bonds with zinc ion. Nitrogen
group of PE forming donor-acceptor bounds with amino acids indicated by arrow. Detailed image of mBFT active center with PC (B) and PE (D).
(Trp fluorescence, selectively, Figures 6C,D) or 280 nm (Trp and
Tyr fluorescence, Figures 6E,F) in the presence of increasing
concentrations of PC organized in liposomes by reverse-phase
evaporation. The results suggest the formation of 1:1 protein-
lipid complexes in a low ionic strength buffer and the formation
of 3:1 mBFT2-lipid complexes in the standard PBS buffer.
Importantly, the presence of larger aggregates with a different
stoichiometry at high lipid concentrations cannot be excluded,
as Trp fluorescence is likely only sensitive to initial saturation.
According to our docking models, non-ester phosphate
oxygen atoms of the lipids tend to form coordinate bonds with
the His-bound zinc ion in the active center of mBFT2. To test
the model and the potential involvement of these coordinate
bonds, we analyzed a BFT2 mutant with no His residues and,
thus, no zinc ions in the active site. Both mutant forms (mBFT2-
mut and pBFT2-mut) demonstrated enhanced affinity to PC,
which may be attributed to their increased hydrophobicity, as the
charged His residues had been replaced with polar but uncharged
Tyr residues. The fact that mBFT2-mut bound with PC more
efficiently than the wild-type protein argues against a major
contribution by zinc to complex formation.
The Trp fluorescence quenching assay demonstrated that the
most represented lipids of the B. fragilis cell membrane (PC and
PE) form complexes with mBFT2, but to determine the lipid
chemical groups capable of such interactions, NMR spectroscopy
was performed. Similar to Trp fluorescence quenching assay
results, constant values (Kd) calculated for PC-mBFT2 and PE-
mBFT2 complexes had slight differences, confirming the specific
nature of a protein-lipid interaction. Thus, PC was used as a
model of protein-lipid complex formation. We used 5µM of
each form of BFT2 (pBFT2 and mBFT2) and 0.6µM PC in a
water solution to study complex formation. Common 1D proton
(with WATERGATE water suppression) (Figures 6A,B) and 2D
DOSY NMR spectra of PC, BFT2 forms and mixtures were
obtained. L-α-phosphatidylcholine (P3556, Sigma Aldrich) was
used as the model PC. We observed that PC formed a micelle
suspension in the water solution. According to the diffusion
NMR spectroscopy results, the micelles consisted of a rather large
number of molecules (∼10 molecules per micelle). This result
corresponds to the literature on this topic (Mashburn-Warren
et al., 2008). The diffusion coefficients of pBFT2 and mBFT2
in water solutions were D = −8.4 log(m2/s) and D = −8.9
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FIGURE 5 | Modeling and docking of protein-lipid A and polysaccharide chain association. Structure model of mBFT and best (according to the binding
energy) ligand–lipid A (A) and polysaccharide chain (C) location on the mBFT Conolly surface, painted depending on the values of the hydrophobic potential—green,
donors–blue, acceptors–red, resulting docking via ICM. Oxygen of lipid phosphate group colored in red forming coordination bonds with zinc ion (indicated by arrow).
The atoms of the ligands are painted in the following colors: Polar hydrogens–blue, nitrogen–dark blue, oxygen–red, phosphorus–orange, carbon–white. Zn ions are
painted in blue. The non-polar hydrogens not shown. Black dot lines indicate hydrogen bonds. Oxygen of lipid phosphate group colored in red forming coordination
bonds with zinc ion. Detailed image of mBFT active center with lipid A (B) and polysaccharide chain (D).
log(m2/s), respectively. The diffusion coefficient for PC in the
water solution was D=−8.2 log(m2/s). The diffusion coefficients
of PC and pBFT2 in the mixture were altered [D = −9.1
log(m2/s) and D = −8.6 log(m2/s), respectively] (Figure 6A)
compared to the diffusion coefficients of each alone. The lipid
molecules in the mixture were less mobile than in micelles in
solution, and the protein molecules were also slightly less mobile
in the mixture. In addition, the chemical shifts and peak widths
of the fatty acid of PC in the mixture were slightly changed.
Peak width changes in this case may be caused only by T2
relaxation time, i.e., by PC mobility or conformation change.
All these changes together may be explained by phospholipids-
protein complex formation. Only one type of diffusion coefficient
for PC and pBFT2 was present in the mixture, indicating that
only one type of protein-phospholipid complex was present in
the solution. The difference between the diffusion of free pBFT
and pBFT2 in complex was not large. Consequently, complex
formation probably causes only a protein conformation change.
The results could be interpreted as the association of small lipid
particles with the protein molecule core and PC shell. The results
of NMR experiments withmBFT2were similar to those described
above (Figure 6B). mBFT2 also formed a complex in mixture
with PC. However, the mBFT2 molecules were also partially self-
aggregated, which was shown by 2D DOSY results. There were
two fractions in the mBFT2 solution with diffusion coefficients
D = −8.9 log (m2/s) and D = −9.3 log (m2/s). The mobility
of the protein was also lower in the mixture with PC than
individually, and PC in the mixture was less mobile as well. The
diffusion coefficients of PC and mBFT2 in mixture were D =
−8.7 log(m2/s) and D = −9 log(m2/s), respectively. The NMR
data have been deposited to UCSD Center for Computational
Mass Spectrometry (MassIVE ID: MSV000080385).
OMV-Associated BFT Is Biologically Active
E-cadherin is a 120-kDa type I transmembrane protein essential
to the intercellular adhesion of adjacent epithelial cells, which are
the primary known substrate for BFT protease activity (Remacle
et al., 2014). Given that mBFT2 was associated with OMVs,
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FIGURE 6 | 500MHz 1D proton. NMR spectra of individual PC, pBFT2, and mBFT2 or their mixture (A,B) and fluorescence quenching assay(C–F). (A) 500MHz
1H-NMR spectra of PC (green), pBFT2 (blue), and their mixture (red), (0–4 ppm region). (B) 500MHz 1H-NMR spectra of PC (green), mBFT2 (blue), and their mixture
(red). (C–F) Trp fluorescence quenching. Conditions: The standard PBS buffer (C–E) or the low ionic strength buffer with Zn (F); excitation at 295 (C,D) or 280 nm (E,F)
20◦C. Protein concentration was 3 nM. Error bars indicate standard deviation for three measurements.
vesicle treatment should promote E-cadherin degradation in HT-
29 cells. Using western blot analysis (Figure 7B), we observed
time-dependent degradation of the 120-kDa subunit E-cadherin
and its complete cleavage after 2 h of treatment with ETBF
OMV in HT-29 cells. To confirm the effect of mBFT2-containing
OMVs of ETBF on E-cadherin degradation, we used NTBFOMV
at the same time points, and there was no effect.
The effect of toxins on E-cadherin could be dependent on
mBFT2 OMV localization. BFT2 can be located inside the
vesicles, in the vesicle membrane, or on the OMV surface.
We produced two types of liposomes that were reverse-phase
constructed with PC. In the first case, the toxin was encapsulated
into the liposomes by a reverse-phase evaporation method, while
in the second case, mBFT2 was added to the prepared liposomes.
We verified the encapsulation of BFT2 into liposomes and
analyzed whether unbound BFT2 was present in the medium
by western blot (Figure 7C). We found that all of the added
BFT2 was associated with liposomes, as we did not observe free
BFT2 in the medium after centrifugation. Two types of liposomes
with mBFT2 and pBFT2 were used for E-cadherin degradation
experiments.
We observed complete E-cadherin degradation in HT-29
cells after 2 h of treatment with liposomes with added mBFT2
(Figure 7A). The same effect was shown using mBFT2 without
liposomes. There was no E-cadherin cleavage when HT-29 cells
were incubated with mBFT2 encapsulated into the liposomes. As
expected, we did not observe any effect of pBFT2 on E-cadherin.
As described previously, OMVs can be used for virulence
factor delivery to host cells. OMVs isolated from ETBF
(Figure 7D) and NTBF (Figure 7E) were labeled with the
lipophilic dye DiI, and two forms of the toxin [mBFT2
(Figure 7F) and pBFT2 (Figure 7G)] were independently added
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FIGURE 7 | Toxin containing liposomes and OMVs show proteolytic activity against HT-29 cell line E-cadherin and form complexes (A–K).
Hemagglutination test (L–M) (A) Biological effects of the toxin to E-cadherin dependent of its localization. 12 nM pBFT2 and 14.2 nM mBFT2 encapsulated into
liposome (pBFT2 inside and mBFT2 inside) or added to prepared liposomes—(pBFT2 outside and mBFT2 outside) were coincubated with HT-29 cells. Recombinant
proteins were also coincubated with HT-29 cells (12 nM pBFT2–pBFT2 recombinant; 14.2 nM mBFT2–mBFT2 recombinant). PBS, DMEM and Free liposomes were
used as negative controls. (B) Biological effect of the toxin containing OMVs to E-cadherin is time depended. 50µg of total ETBF OMV proteins were coincubated
with HT-29 cells for 15 min (ETBF OMV for 15 min), for 1 h (ETBF OMV for 1 h), for 2 h (ETBF OMV for 2 h). The same amounts of NTBF OMV proteins were
coincubated with HT-29 cells for 15 min (NTBF OMV for 15 min) or for 2 h (NTBF OMV for 2 h). Extracted HT-29 cells proteins (A,B) were run on 10% SDS-PAGE
followed by western blot with antibody against E-cadherin. (C) Toxin encapsulation and toxin-liposome association were examined by western blot. 14.2 nM mBFT2
with previously added prepared liposomes were dissolved in sterile culture media. After ultracentrifugation step supernatant was examined to unbound toxin—(lane 1),
14.2 nM mBFT2 encapsulated into the liposomes were treated with Proteinase K (20 ng/µl) and run on 10% SDS-PAGE followed by western blot with antibody
against mBFT2–(lane 2). Recombinant protein—14.2 nM mBFT2—lane 3. (D–K) Complexes formation was examined by fluorescent microscopy. 3µg OMVs, isolated
from ETBF-(D) and NTBF-(E); 12 nM pBFT2-(F) and 14.2 nM mBFT2-(G) were added to 100µl prepared liposomes; 14.2 nM mBFT2-(H) and 12 nM pBFT2-(I) were
encapsulated into the liposomes. (J)-10µl VybrantDiI were added to PBS and centrifuged at 100,000 g. (K)-100µl liposomes. All samples (D–I, K) were labeled with
VybrantDiI (red) and coincubated with HT-29 cells for 1 h. Nuclei were stained with DAPI (blue). Arrows indicate protein-lipid complexes located on cells surfaces.
(L)-Hemagglutination activity of mBFT2 depends on toxin concentration. (M)-Hemagglutination activity of mBFT2 and pBFT2 in a presence of LPS.
to the prepared liposomes and then incubated with HT-29
cells for 1 h. We also tested two forms of the toxin [mBFT2
(Figure 7H) and pBFT2 (Figure 7I)] encapsulated in liposomes
for their ability to form complexes. As a control, we used free
DiI-labeled liposomes that were also incubated with HT-29 cells
for 1 h (Figure 7J). Moreover, to reduce possible false positive
cell coloring, we dissolved 10 µl of stock DiI solution in PBS and
centrifuged it at 100,000 × g; the resulting sediment dissolved in
PBS was used for HT-29 cell labeling (Figure 7K). In agreement
with our previous results, mBFT2 and pBFT2 added to the
prepared liposomes formed complexes located on the cell surface
(Figure 7F,G, protein-lipid complexes indicated by arrows).
We observed ETBF OMVs and NTBF OMVs located on the cell
surface, confirming that OMVs are used for protein delivery.
Additionally, the relatively few NTBF OMVs located on the cell
surface compared with ETBF OMVs may indicate that the toxin
facilitates adherence between OMVs and cell membranes. We
did not observe any labeled liposomes with encapsulated toxins
on the cell surface, confirming the role of the toxin in complex
formation.
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Hemagglutination Test
Since pBFT2 and mBFT2 tend to form H-bonds and coordinate
bonds with membrane components, including LPS, we examined
the hemagglutination and lectin activity for both types of
the toxin. First, increasing concentrations (0.1–2.5µg) of
mBFT2 were tested for the ability to induce hemagglutination.
We detected erythrocyte hemagglutination with mBFT2 at
concentrations of 2.5 and 2µg (Figures 7L,M). pBFT2 did
not demonstrate hemagglutination activity. We also identified
inhibition of hemagglutination when mBFT2 was premixed
with LPS isolated from ETBF and NTBF. LPS alone did not
demonstrate hemagglutination activity (Figure 7M).
DISCUSSION
OMVs are considered to be one of the types of bacterial secretion
system. Moreover, this secretion mechanism is well known in
B. fragilis (Patrick et al., 1996; Elhenawy et al., 2014). Recently
it has been described that B. fragilis contains T6SS, which is
likely a source of numerous novel effector and immunity proteins
(Coyne et al., 2016). But there is no evidence that this could be the
mechanism for toxin secretion. In our study we hypotized that
OMVs can be utilized for B. fragilis toxin secretion.
In our experiments, we demonstrated that both strains (ETBF
andNTBF) of B. fragilis produce vesicles, andwe detectedmBFT2
in vesicles by western blot assay, suggesting that OMVs could be
the mechanism of BFT secretion. As expected, microscopy assay
results were in agreement with cells fractions and OMVs western
blot results. We observed labeled antibodies against BFT2 in
the periplasm, in membrane and in the vesicle membranes.
Moreover, pBFT2 was detected primarily in membrane fraction
but was not detected in OMVs suggesting possible toxin
maturation in cells membrane. An NTBF cell fraction and OMVs
isolated from NTBF culture were used as negative controls in all
experiments.
The main visual biological effect of toxin exposure is that
mBFT2 affects zonula adherens by cleaving E-cadherin. We used
OMVs isolated from ETBF and NTBF to evaluate their biological
activity against E-cadherin. As expected, we detected time-
dependent E-cadherin degradation upon ETBF OMV treatment,
but no degradation with NTBF OMV treatment, confirming that
the toxin is active and associated with OMVs.
According to a recent publication, there is a special
mechanism of OMV protein sorting. It was shown in
Campylobacter jejuni that CDT toxin is not associated with
membranes and is localized on the inner surface of the vesicles.
This result was confirmed by OMV protease treatment, during
which the toxin was not degraded because it was inside the
vesicles (Lindmark et al., 2009). We used Proteinase K (20 ng/µl)
treatment to determine possible toxin localization by western
blot analysis and found that BFT2 was fully degraded within
10min of Proteinase K treatment. These results indicate that
the toxin is located on the OMV surface. To confirm surface-
located toxin activity against E-cadherin, we prepared several
types of liposomes with different localizations of the mBFT2.
pBFT2 was used as a negative control because the immature
toxin form does not contribute to E-cadherin degradation (Wu
et al., 1998). In HT-29 cells treated with all liposome-toxin
preparations, we observed E-cadherin degradation only when the
toxin was added to the previously prepared liposomes, indicating
that OMV-associated BFT2 is located on OMV surface. We
observed toxin-liposome complexes labeled with the lipophilic
dye DiI on the surface of HT-29 cells. Complex formation
occurred only in the presence of toxin, which acted as an adhesive
element. As expected, both types of OMV (isolated from ETBF
and NTBF) were found on the HT-29 cell surface. Most likely, the
ETBF and NTBF vesicle membranes contain adhesion proteins
that facilitate OMV binding to the cell surface followed by
internalization.
BFT could interact with a membrane protein receptor
sensitive to depletion of membrane cholesterol (Wu et al., 2006).
In this study, we hypothesized that BFTs interact with OMV
membrane components, including phospholipids and LPS before
binding with the potential receptor. First, we identified the B.
fragilis membrane lipids and LPS using mass spectrometry. As
expected, the most represented ions in the spectrum belonged
to PE and PC classes, as they are prevalent lipid components
of gram-negative bacteria membranes (Epand et al., 2007).
Furthermore, we identified the lipid A and polysaccharide chain
structures of B. fragilis LPS.
These results were further used for modeling and docking
experiments. The mass spectrometric analysis results we
obtained completely corresponded to data previously reported
by Elhenawy et al. (2014). It should be noted that Elhenawy
et al. previously characterized the same structure of lipid A
and showed no difference between bacterial outer membrane
and OMV lipid A structure. We identified that B. fragilis LPS
consisted of a poly- and oligosaccharide region composed by
monogalactosyl and -glucosyl units (up to 8 carbohydrate units
in the chain) linked to lipid A-disaccharide.
We used the identified phospholipids, lipid A, and
polysaccharide chain structures to model their interaction
with mBFT2 and pBFT2. Polysaccharide chain and lipid A
showed comparable binding energy values in docking with
mBFT2. As expected, we observed the formation of multiple
H-bonds between monosaccharide units of polysaccharide chain
and amino acid residues of mBFT2, but an unusual effect was
the coordinate bond formation between the oxygen of phosphate
groups and zinc ion. This interaction is similar to the formation
of non-covalent bonds in lectins, which have special binding
sites for polysaccharides and form coordinate bonds with metal
ions (Sharon, 1987; Abhilash et al., 2013). However, lectins are
characterized by non-covalent interaction with sugars, not with
lipids. The docking procedure for pBFT2 and LPS components
was not performed because we did not expect the immature form
of the protein to bind to LPS.
Despite the fact that mBFT2 is a soluble protease, we
demonstrated, through the docking modeling that both mBFT2
and pBFT2 might hydrophobically interact with phospholipids.
Carbonyl oxygen atoms of PC/PE (as it was shown for LPS
components) formed coordinate bonds with the zinc ion located
in the active center of mBFT2 after its processing. By diffusion
NMR spectroscopy and Trp fluorescence quenching assays,
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we evaluated the formation of pBFT2-lipid and mBFT2-lipid
complexes. NMR data indicated that the fatty acid residues
participate directly in these interactions. The mutant protein
mBFT2-mut, which does not contain a zinc ion in the active site,
demonstrated enhanced affinity for PC, which argues against a
major role for the coordinate bonds. We also observed enhanced
affinity of the mutant form of pBFT2 for PC, which could result
from the conformational alterations caused by the mutation or
somewhat increased hydrophobicity.
High lipid-protein tropism was also shown in cell culture
experiments. The formation of mBFT2-lipid complexes
associated with the cell surface was demonstrated by microscopic
assay. It was also shown that labeled vesicles were located on
the cell surface. Our microscopy results confirmed previous
experiments reported by Sears et al. where labeled recombinant
toxin was also located on the cell surface (Wu et al., 2006).
Based on the obtained results, we propose a mechanism
of toxin secretion (Figure 8). pBFT2 interacts with cellular
membrane lipids and accumulates in the inner membrane.
In periplasm possibly it undergoes processing via proteolytic
cleavage by a B. fragilis cysteine protease, forming the active
version of the toxin (mBFT2) (Herrou et al., 2016). Oxygen atoms
of lipid phosphate groups located on the inner surface of the
outer membrane bilayer interact with the active center of mBFT2,
simultaneously forming coordinate bonds with the zinc ion.
Thermal motion of the protein leads to a local stretching of the
lipid, facilitating the cessation of hydrophobic interactions with
its membrane pair. Fatty acid tails of lipids tend to occupy the free
grooves in mBFT2, resulting in the promotion of mBFT2 outside
the outer membrane. At this point, vesicle formation could
occur, and the toxin incorporated into the OMV membrane will
be delivered to the host cell. However, the proposed model of
toxin promotion through the membrane does not exclude the
possibility of potential secretion system involvement.
The protein could also be promoted to the OMV surface,
forming new, stronger electrostatic and hydrogen bonds with
LPS components and disrupting previous focal and hydrophobic
bonds between the lipid and protein. Further protein motion
becomes impossible due to significant hydrogen bond formation
between the LPS carbohydrate moiety and the toxin. The
same protein-carbohydrate communication was demonstrated
previously in numerous studies for lectins (Soult et al., 2014).
Lectins and carbohydrates are linked by a number of relatively
weak interactions that ensure specificity. The interactions
between one cell surface with carbohydrates and another with
lectins resemble the action of Velcro in that each interaction
is relatively weak but the composite is strong. Today, the
adhesins and toxins produced by Vibrio cholerae, Shigella
dysenteriae, and Bordetella pertussis are the most significant
microbial lectins (Sandros et al., 1994). To confirm the potential
lectin activity of mBFT2, we tested the ability of the toxin to
induce hemagglutination. Here, we show for the first time that
mBFT2 has hemagglutination activity. However, lectin activity
was determined by the ability of LPS to inhibit hemagglutination.
We premixed mBFT2 with LPS isolated from ETBF and NTBF
and demonstrated alteration of the hemagglutination activity
of mBFT2. Erythrocytes tended to form pellets when LPS had
been mixed with mBFT2. Of note, pBFT2 did not display
hemagglutination activity. We suggest that pBFT2 does not
have the ability to induce hemagglutination but acquires this
property during processing. Two forms of the toxin that have
different hemagglutination properties might also exhibit different
interaction with lipids. Thus, we demonstrated that mBFT2 has
strong lectin activity that could be necessary for its biological
functions.
We believe that the strong lectin-like protein-membrane
association identified here could be used in two potential
mechanisms of toxin-host cell interaction. Toxin-lipid or
toxin-LPS association leading to the local toxin concentration
increasing on the surface of target cells may increase contact of
the toxin with a corresponding substrate or receptor. Moreover,
toxin associated with vesicles could be taken up via endocytosis
by eukaryotic cells or undergo a membrane flip-flop mechanism
and persist in the intracellular environment.
MATERIALS AND METHODS
Bacterial Strains and Growth Conditions
Enteropathogenic B. fragilis BOB25 (Nikitina et al., 2015)
and non-toxigenic B. fragilis 323-J-86 (clinical isolates kindly
provided from the Federal Research and Clinical Centre of
Physical-Chemical Medicine Federal Medical Biological Agency,
Moscow, Russia) were grown on blood agar plates containing
either 5% defibrinated horse blood or brain heart infusion broth
supplemented with hemin (5 g/ml) under anaerobic conditions.
Cell Line Medium and Culture Conditions
Human colonic epithelial cells (HT-29) obtained from the
American Type Culture Collection (ATCC Number HTB-38)
were seeded in 25 cm2 flasks at 37◦C under 5% CO2 in
DMEM (Life Technologies, USA) containing 10% fetal bovine
serum (FBS, Life Technologies, USA) and 2mM GlutaMax (Life
Technologies, USA).
Recombinant Proteins and Antibodies
Immature and mature forms of recombinant toxins (mBFT2,
pBFT2) were prepared as described previously (Kharlampieva
et al., 2015). The mutant forms of BFT (mBFT2-mut, pBFT2-
mut) were obtained by site-directed mutagenesis, where zinc-
chelating histidine residues were mutated to tyrosine residues
(H348Y, H352Y, and H358Y). Detailed information about how
the mutant forms of the toxin have been described previously
(Kharlampieva et al., 2015).
For BFT2-specific antibody preparation, 100µg recombinant
pBFT2 in 1x PBS was injected to rabbits four times at intervals of
3–4 weeks. Fourteen days after the final injection, 15ml blood
was collected. Immunoglobulin fraction separation from the
serum was performed with protein A-sepharose.
OMV Purification
Overnight-cultured B. fragilis (ETBF and NTBF) strains were
centrifuged at 4500 × g at 4◦C. To remove residual cells, the
supernatant was filtered using a 0.45-µmpore membrane (Millex
GV; Millipore). The filtrate was subjected to ultracentrifugation
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FIGURE 8 | Model of toxin capture during vesicle formation. Toxin is shown as complex of two subunits. Part of the toxin that will be processed (pBFT) and
degraded is colored in dark green. Active part of the toxin (mBFT) colored in orange. OM, outer membrane; LPS, lipopolysaccharide; PG, peptidoglycan; PP,
periplasm; IM, inner membrane; CYT, cytoplasma. At the beginning of vesicle formation, the major part of the toxin is not processed and could be found in membrane.
During vesicle formation toxin could be processed by B. fragilis cysteine protease. Free grooves, located on the protein surface, formed during toxin processing
interact with fatty acid residues of outer membrane lipids by hydrophobic interaction. Toxin promoted to the OMV surface where it interact with LPS. Incorporated or
tightly binding toxin delivered to the target cell by OMVs.
at 100,000 × g for 2 h (Optima L-90K ultracentrifuge; Beckman
Coulter). The supernatant was discarded, and the pellet was
washed with sterile PBS and filtered through a 0.2-µm
pore polyvinylidene difluoride (PVDF) membrane (Millex GV;
Millipore). The ultracentrifugation step was repeated. The
vesicle pellet was resuspended in 150 mM NaCl (pH 6.5).
Protein concentration was quantified using a 2D-quant kit (GE
Healthcare Life Sciences).
Cell Fractionation
Cell fractionation was performed as described by Lindmark et al.
(2009). Precipitated proteins from cell fractions were collected
by centrifugation at 12,000 × g, washed with acetone, dried and
dissolved in Laemmli sample buffer. Protein concentration was
quantified using a 2D-quant kit (GE Healthcare Life Sciences). In
total, 40–60µg each extract sample was used for SDS-PAGE and
western blot assay.
Cells Fractions LC-MS/MS Analysis
Detail information about SDS PAGE and In-gel trypsin
digestion of cell fractions proteins can be found in Supplemental
information 2. LC-MS/MS analysis of tryptic peptides was carried
out using Ultimate-3000 HPLC system (Thermo Scientific)
coupled to a maXis qTOF after HDC-cell upgrade (Bruker)
with a nano-electrospray source. Chromatographic separation
of peptides was performed on a C-18 reversed phase column
(Zorbax 300SB-C18, 150mm x 75 um, particle diameter 3.5 um,
Agilent). Gradient parameters were as follows: 5–35% acetonitrile
in aqueous 0.1% (v/v) formic acid, duration 120min, column
flow 0.3 ul/min. Positive MS and MS/MS spectra were aquired
using AutoMS/MS mode (capillary voltage 1700, curtain gas flow
4 l/min, curtain gas temperature 170 C, spectra rate 10Hz, 4
precursors, m/z range 50–2200, active exclusion after 2 spectra,
release after 0.5min). Detail information about Search Database
Creation and Proteins and Peptides Identification can be found
in Supplemental information 2.
SDS-PAGE and Western Blot Analysis
The isolated OMVs and different cellular extracts were mixed
with Laemmli sample buffer (1:1) containing CHAPS and
separated by SDS-PAGE. A total of 40µg each (NTBF and
ETBF) OMV sample and 40–60µg periplasmic, cytoplasmic, and
membrane fractions were used for SDS-PAGE and subsequent
western blot analysis. We used BFT2-specific antibodies and
horseradish peroxidase-linked anti-rabbit IgG (from sheep,
dilution 1:10,000, GE Healthcare, USA). The membranes were
processed with ECL Plus western blot detection reagents (GE
Healthcare, USA) according to the manufacturer’s guidelines.
The signals were detected on a ChemiDoc MP (BioRad, USA).
Electron Microscopy and Immunogold
Labeling
Ultrathin sections of ETBF and NTBF cells were prepared as
previously described (Farquhar, 1956). A volume of 5 µl of each
OMV samples was negatively stained with 2% (wt/vol) uranyl
acetate for 3 min and examined using a Zeiss Libra 120 electron
microscope (Zeiss, Germany).
For immunogold labeling, cells were fixed by the addition of
formaldehyde and glutaraldehyde to final concentrations of 4
and 0.1–0.2%, respectively, dehydrated with ethanol in increasing
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concentrations (70, 96%) and embedded in LR-White resin
(Polyscience, INC, USA). To visualize the distribution of the BFT
protein in B. fragilis cells, BFT2-specific antibodies diluted 1:50
in PBS (1×) and conjugates of protein A with 15 nm colloid
gold particles (Aurion, The Netherlands) were used. OMVs
were adsorbed onto carbon-coated nickel grids for 2min and
coincubated with labels, coupled with antibodies against BFT,
and then negatively stained. Immunogold labeled samples were
examined using a Zeiss Libra 120 electron microscope (Zeiss,
Germany).
Lipid Extraction
For lipid extraction, 1 ml liquid culture (ETBF and NTBF) was
used. Samples were incubated at –77◦C for 15 min, then at room
temperature for 3 min and centrifuged at 10,000 × g for 20
min. The resulting cell pellets were used for lipid extraction by
a modified Folch protocol (Folch et al., 1957). LPS was isolated
using the Tri-Reagent method described by Yi and Hackett
(2000).
Shot-Gun Lipidomics
Identification of extracted membrane lipids and LPS was
performed using a quadrupole time-of-flight tandem mass
spectrometer (Q-TOF Maxis, Bruker Daltonics, Germany)
with an updated collision cell for electrospray ionization
source. Metabolite identification was confirmed by the
fragmentation of the detected parent ions. External phospholipid
standards (choline, phosphatidylcholine, phosphatidylserine,
phosphatidylethanolamine, phosphatidylglycerol, phosphatidic
acid, and tetracycline; Sigma Aldrich) were used to optimize
the MS/MS-acquisition conditions. We used the following
databases for lipid identification: LIPID MAPS database (LIPID
MAPS Lipidomics Gateway, a free resource sponsored by the
National Institute of General Medical Sciences, USA; http://
www.lipidmaps.org), Byrdwell G. Resources for Lipid Analysis
in the twenty-first Century (http://www.byrdwell.com), Metlin
(Scrips Center for Mass Spectrometry, USA; https://masspec.
scripps.edu) and Galactosylceramides and Glucosylceramides
(Cerebrosides) (http://www.lipidhome.co.uk/).
Modeling and Docking
No BFT2 crystal structures have been reported thus far, so
the atom coordinates for creating 3D models of this protein
were taken from the XRD-based structure of its homolog
BFT3 (PDB: 3p24 http://www.rcsb.org/pdb/explore/explore.do?
structureId=3p24) by substituting several amino acid residues
(see Supplemental information 2). The 3D models of the targets
(PE, PC, Lipid A, and polysaccharide chain of LPS) were created
with the Molsoft ICM version 3.8–3 application (Wesson and
Eisenberg, 1992; Abagyan et al., 1994; Totrov and Abagyan,
2001a,b). Detailed information about the modeling and docking
procedure can be found in Supplemental information 2.
Trp Fluorescence Quenching Assay
Intrinsic fluorescence of the Trp and Tyr residues was measured
after the addition of different amounts of vesicles constructed
from PC to 3 nM mBFT, pBFT2, mBFT2, pBFT-mut, mBFT-
mut, Proteinase K, or BSA solutions in the standard PBS buffer
(Merck) or a low ionic strength buffer (1 nM ZnSO4 in 1:50
diluted PBS). Each protein solution was mixed gently after the
addition of the PC vesicles and stored at room temperature for
1–2 min prior to measurements. Fluorescence emission spectra
were registered at 20◦C using a Chirascan spectrometer (Applied
Photophysics) equipped with a thermostatically controlled
cuvette holder with slit widths of 4 and 6 nm upon excitation
at 280 or 295 nm. Light scattering by liposomes was taken into







where Y is fluorescence quenching and n is the Hill coefficient (n
= 1± 0.3 unless otherwise specified).
Fitting was performed using DataFit 9 software.
NMR Analysis of Protein-Lipid Complexes
The samples for NMR spectroscopy [500µg mBFT2, 500µg
phosphatidylcholine (Sigma Aldrich, USA)] were dissolved in
water (100µl D2O was added to each sample for the lock signal
stabilization) and phosphate buffer (pH 7.4). All spectra were
obtained on a Bruker Advance III 500 MHz NMR spectrometer
(Bruker, USA) equipped with a Prodigy TCI cryogenic triple-
channel probe. The sample temperature was kept at 300K
during the experiments. 2D DOSY (the stimulated echo pulse
sequence with bipolar gradient pulses was used) and common
1D proton spectra were measured for the study of protein-lipid
complex formation (Chou et al., 2004; Balayssac et al., 2009). The
water peak in all experiments was suppressed by WATERGATE
pulse sequence with five pairs of symmetric gradients (125 ms
delay for binomial water suppression and 200 ms delay for
gradient recovery). The NMR data processing and analysis were
performed using Bruker TopSpin v.3.2 NMR.
Preparation of Liposomes by
Reverse-Phase (REV) Evaporation
To prepare liposomes, 30µl phosphatidylcholine or
phosphatidylethanolamine in chloroform solution (100 mg/ml)
and 300µl PBS with 1ml diethyl ether were added to a 50 ml
round-bottom flask with a long extension neck, and the solvent
was removed under reduced pressure by a rotary evaporator.
Prepared liposomes were dissolved in 200µl PBS.
Cell Culture Experiments
To examine the biological activity of BFT2-containing OMVs,
HT-29 cells were co-incubated for 2 h with 40–60µg total OMV
proteins isolated from ETBF and NTBF. After co-incubation,
cells were washed with 1x PBS buffer several times and mixed
with 50µl 1x Laemmli sample buffer containing CHAPS. To
detect E-cadherin cleavage, western blot analysis with E-cadherin
monoclonal mouse antibody (dilution 1:1000, Invitrogen, USA)
and horseradish peroxidase-linked anti-mouse IgG (from sheep,
dilution 1:10,000, GE Healthcare, USA) was performed. The
membranes were processed with ECL Plus western blot detection
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reagents (GE Healthcare, USA) according to the manufacturer’s
guidelines. The signals were detected on a ChemiDoc MP
(BioRad, USA).
To determine mBFT2 localization (on the outer or inner
surface of the OMV membrane) essential for biological
activity against E-cadherin, two different types of liposomes
were obtained by reverse-phase evaporation. For encapsulated
toxin preparation, 14.2 ng mBFT2 and 12 nM pBFT2
were encapsulated into 30µl (100 mg/ml) liposomes by
reverse-phase evaporation method, described earlier (“Material
and Methods”—“Preparation of liposomes by reverse-phase
(REV) evaporation”). Proteolysis of unencapsulated mBFT2
was performed using Proteinase K (20 ng/µl) treatment. Toxin
encapsulation was verified by western blot with BFT-specific
antibodies. For the toxin added to the prepared liposomes, 14.2
ng mBFT2 and 12 nM pBFT2 were added to 30µl previously
prepared liposomes (100 mg/ml), and the mBFT2-liposome mix
was purified by one ultracentrifugation step at 100,000 × g
for 1 h. The amount of unbound mBFT2 in the medium was
determined by western blot with BFT2-specific antibodies. Both
types of liposomes were co-incubated with HT-29 cells for 1
h. After incubation, cells were washed several times with 1 ×
PBS and mixed with 50µl 1x Laemmli sample buffer containing
CHAPS. To detect E-cadherin cleavage, western blot analysis with
anti E-cadherin antibody was performed.
For visual assessment of protein-lipid complexes
(mBFT2/pBFT2-liposomes) and OMV fixed on the cell
surface, fluorescence microscopy was performed. Briefly,
isolated OMVs of NTBF and ETBF (40µg each) and 50µl
prepared liposomes (100mg/ml) were separately labeled with
Vybrant DiI in a 30 min incubation and purified again by
one step of ultracentrifugation at 100,000 × g for 1 h. Labeled
OMVs, liposomes alone, prepared liposomes with added
mBFT2 or pBFT2 and encapsulated toxin preparations were
co-incubated with HT-29 cells for 1 h. The cells were then
washed ∼three times, incubated with DAPI for nuclei labeling
and observed with a Nikon Eclipse E800 microscope (Nikon,
Japan) or an Olympus Live Cell Imaging System (Olympus IX51,
Japan).
Hemagglutination Assay
A hemagglutination assay was performed using red blood cells
(RBCs) from humans. Blood was provided by volunteer donors
(Lewis Oα−β+). Written informed consent from participants was
obtained and approved by the ethical committee of the Federal
Research and Clinical Centre of Physical-Chemical Medicine
Federal Medical Biological Agency, Moscow, Russia (approval
number 1a/2016). Heparinized whole human blood erythrocytes
were washed three times by centrifugation at 200 × g and
resuspended to 1.5% packed cell volume in 1× PBS. mBFT2 in
increasing concentrations (0.1–2.5µg), 5µl LPS (isolated from
20 ml ETBF and 20 ml NTBF) and pBFT (2.5 and 1µg) were
independentlymixed with the erythrocyte suspension in a round-
bottomed 96-well dish and agitated by hand. Separately, mBFT2
(2 µg) was premixed with ETBF LPS or NTBF LPS, and then
prepared solutions were mixed with the erythrocyte suspension
in a round-bottomed 96-well dish and agitated by hand. A
positive result was recorded if hemagglutination occurred within
10 min.
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